High-risk metastatic gestational trophoblastic disease: further stratification into two clinical entities. 1989

A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
Department of Gynecology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.

Forty-two of sixty-seven patients (62.7%) treated for high-risk metastatic trophoblastic disease achieved and maintained complete remissions. The survival rate was significantly improved in those patients with scores lower than 8 according to a modification of the World Health Organization (WHO) prognostic scoring system. A low score was associated with a higher probability of response to single-agent therapy, although the difference was not statistically significant. The score, however, was significantly associated with response to multiagent chemotherapy with methotrexate, actinomycin D, and cyclophosphamide (P = 0.0004). Therefore, future trials of new combinations of chemotherapy in high-risk patients should be stratified according to the patients' prognostic scores.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014328 Trophoblastic Neoplasms Trophoblastic growth, which may be gestational or nongestational in origin. Trophoblastic neoplasia resulting from pregnancy is often described as gestational trophoblastic disease to distinguish it from germ cell tumors which frequently show trophoblastic elements, and from the trophoblastic differentiation which sometimes occurs in a wide variety of epithelial cancers. Gestational trophoblastic growth has several forms, including HYDATIDIFORM MOLE and CHORIOCARCINOMA. (From Holland et al., Cancer Medicine, 3d ed, p1691) Trophoblastic Cancer,Trophoblastic Tumor,Neoplasms, Trophoblastic,Trophoblast Cancer,Trophoblast Neoplasms,Trophoblast Tumor,Cancer, Trophoblast,Cancer, Trophoblastic,Cancers, Trophoblast,Cancers, Trophoblastic,Neoplasm, Trophoblast,Neoplasm, Trophoblastic,Neoplasms, Trophoblast,Trophoblast Cancers,Trophoblast Neoplasm,Trophoblast Tumors,Trophoblastic Cancers,Trophoblastic Neoplasm,Trophoblastic Tumors,Tumor, Trophoblast,Tumor, Trophoblastic,Tumors, Trophoblast,Tumors, Trophoblastic
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
September 1988, Obstetrics and gynecology clinics of North America,
A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
February 1988, Gynecologic oncology,
A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
March 1994, The Journal of reproductive medicine,
A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
January 1991, The Journal of reproductive medicine,
A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
January 1998, European journal of gynaecological oncology,
A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
September 1988, Obstetrics and gynecology clinics of North America,
A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
April 1981, The Journal of reproductive medicine,
A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
September 1987, The Journal of reproductive medicine,
A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
January 1998, The Journal of reproductive medicine,
A N Gordon, and D M Gershenson, and L J Copeland, and C A Stringer, and M Morris, and J T Wharton
September 1987, The Journal of reproductive medicine,
Copied contents to your clipboard!